Long noncoding RNA cancer susceptibility candidate 2 suppresses papillary thyroid carcinoma growth by inactivating the AKT/ERK1/2 signaling pathway
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Long noncoding RNA cancer susceptibility candidate 2 suppresses papillary thyroid carcinoma growth by inactivating the AKT/ERK1/2 signaling pathway
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR BIOCHEMISTRY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-01-05
DOI
10.1002/jcb.28322
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Upregulation of CASC2 sensitized glioma to temozolomide cytotoxicity through autophagy inhibition by sponging miR-193a-5p and regulating mTOR expression
- (2018) Chunming Jiang et al. BIOMEDICINE & PHARMACOTHERAPY
- Integrated analysis of differentially expressed profiles and construction of a competing endogenous long non-coding RNA network in renal cell carcinoma
- (2018) Qianwei Xing et al. PeerJ
- Identification of lncRNAs and Their Functional Network Associated with Chemoresistance in SW1990/GZ Pancreatic Cancer Cells by RNA Sequencing
- (2018) Duguang Li et al. DNA AND CELL BIOLOGY
- Clinical Significance of Serum lncRNA Cancer Susceptibility Candidate 2 (CASC2) for Chronic Renal Failure in Patients with Type 2 Diabetes
- (2018) Linxia Wang et al. MEDICAL SCIENCE MONITOR
- LncRNA CASC2 Interacts With miR-181a to Modulate Glioma Growth and Resistance to TMZ Through PTEN Pathway
- (2017) Yiwei Liao et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- The prognostic value of abnormally expressed lncRNAs in colorectal cancer: A meta-analysis
- (2017) June Wang et al. PLoS One
- Central Neck Dissection for Papillary Thyroid Cancer
- (2017) David T. Hughes et al. Cancer Control
- Discovery and functional analysis of lncRNAs: Methodologies to investigate an uncharacterized transcriptome
- (2016) Kaori Kashi et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Downregulation of lncRNA CASC2 by microRNA-21 increases the proliferation and migration of renal cell carcinoma cells
- (2016) YUNJIE CAO et al. Molecular Medicine Reports
- Low expression of long noncoding RNA CASC2 indicates a poor prognosis and regulates cell proliferation in non-small cell lung cancer
- (2016) Xuezhi He et al. TUMOR BIOLOGY
- Next-generation sequencing reveals novel differentially regulated mRNAs, lncRNAs, miRNAs, sdRNAs and a piRNA in pancreatic cancer
- (2015) Sören Müller et al. Molecular Cancer
- The PI3K/AKT/mTOR pathway in the pathophysiology and treatment of pituitary adenomas
- (2014) Eric Monsalves et al. ENDOCRINE-RELATED CANCER
- The Importance of the PI3K/AKT/MTOR Pathway in the Progression of Ovarian Cancer
- (2013) Zachary Dobbin et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Thyroid Cancer: Burden of Illness and Management of Disease
- (2012) Rebecca L. Brown et al. Journal of Cancer
- The Emergence of lncRNAs in Cancer Biology
- (2011) J. R. Prensner et al. Cancer Discovery
- Central Neck Dissection for Papillary Thyroid Cancer
- (2009) Michael A. Rosenbaum et al. ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY
- Evolution and Functions of Long Noncoding RNAs
- (2009) Chris P. Ponting et al. CELL
- Thyroid Cancer in Young Adults
- (2009) Anita K. Ying et al. SEMINARS IN ONCOLOGY
- Polyinosinic-polycytidylic acid liposome induces human hepatoma cells apoptosis which correlates to the up-regulation of RIG-I like receptors
- (2008) Shuo Peng et al. CANCER SCIENCE
- Phosphatidylinositol 3-Kinase/Akt and Ras/Raf-Mitogen-Activated Protein Kinase Pathway Mutations in Anaplastic Thyroid Cancer
- (2007) Libero Santarpia et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now